» Articles » PMID: 32446219

Human Pluripotent Stem Cell-derived Cardiac Stromal Cells and Their Applications in Regenerative Medicine

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2020 May 24
PMID 32446219
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Coronary heart disease is one of the leading causes of death in the United States. Recent advances in stem cell biology have led to the development and engineering of human pluripotent stem cell (hPSC)-derived cardiac cells and tissues for application in cellular therapy and cardiotoxicity studies. Initial studies in this area have largely focused on improving differentiation efficiency and maturation states of cardiomyocytes. However, other cell types in the heart, including endothelial and stromal cells, play crucial roles in cardiac development, injury response, and cardiomyocyte function. This review discusses recent advances in differentiation of hPSCs to cardiac stromal cells, identification and classification of cardiac stromal cell types, and application of hPSC-derived cardiac stromal cells and tissues containing these cells in regenerative and drug development applications.

Citing Articles

Fusing spheroids to aligned μ-tissues in a heart-on-chip featuring oxygen sensing and electrical pacing capabilities.

Schneider O, Moruzzi A, Fuchs S, Grobel A, Schulze H, Mayr T Mater Today Bio. 2022; 15:100280.

PMID: 35601892 PMC: 9120495. DOI: 10.1016/j.mtbio.2022.100280.


[Effects of two common acellular methods on the physicochemical properties of dermal acellular matrix].

Yang C, Guo J, Wang J, Fan J, Xing Y, Zhang L Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2021; 38(5):911-918.

PMID: 34713659 PMC: 9927432. DOI: 10.7507/1001-5515.202103019.


Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype.

Floy M, Givens S, Matthys O, Mateyka T, Kerr C, Steinberg A FASEB J. 2021; 35(9):e21799.

PMID: 34339055 PMC: 8349112. DOI: 10.1096/fj.202100523R.


Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion.

Madonna R, Guarnieri S, Kovacshazi C, Gorbe A, Giricz Z, Geng Y J Cell Mol Med. 2021; 25(12):5381-5390.

PMID: 33949765 PMC: 8184669. DOI: 10.1111/jcmm.16549.


Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.

Perry T, Roberts M, Sunkara B, Maddula R, McLeish T, Gomez J Curr Oncol Rep. 2021; 23(7):77.

PMID: 33937943 PMC: 8088904. DOI: 10.1007/s11912-021-01066-2.

References
1.
Generali M, Casanova E, Kehl D, Wanner D, Hoerstrup S, Cinelli P . Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells. Acta Biomater. 2019; 97:333-343. DOI: 10.1016/j.actbio.2019.07.032. View

2.
Anbara T, Sharifi M, Aboutaleb N . Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular Diseases. Curr Cardiol Rev. 2019; 16(4):306-314. PMC: 7903503. DOI: 10.2174/1573403X15666190808100336. View

3.
Hastie N . Wilms' tumour 1 (WT1) in development, homeostasis and disease. Development. 2017; 144(16):2862-2872. DOI: 10.1242/dev.153163. View

4.
Jonsson M, Hartman R, Ackers-Johnson M, Tan W, Lim B, van Veen T . A Transcriptomic and Epigenomic Comparison of Fetal and Adult Human Cardiac Fibroblasts Reveals Novel Key Transcription Factors in Adult Cardiac Fibroblasts. JACC Basic Transl Sci. 2018; 1(7):590-602. PMC: 6113540. DOI: 10.1016/j.jacbts.2016.07.007. View

5.
Asp M, Giacomello S, Larsson L, Wu C, Furth D, Qian X . A Spatiotemporal Organ-Wide Gene Expression and Cell Atlas of the Developing Human Heart. Cell. 2019; 179(7):1647-1660.e19. DOI: 10.1016/j.cell.2019.11.025. View